Skip to main content
Tobacco Control logoLink to Tobacco Control
. 2001 Mar;10(1):55–61. doi: 10.1136/tc.10.1.55

Development of the health and economic consequences of smoking interactive model

M Orme 1, S Hogue 1, L Kennedy 1, A Paine 1, C Godfrey 1
PMCID: PMC1763982  PMID: 11226362

Abstract

OBJECTIVE—To describe the health and economic consequences of smoking model, a user friendly, web based tool, designed to estimate the health and economic outcomes associated with smoking and the benefits of smoking cessation.
RESULTS—An overview of the development of the model equations and user interface is given, and data from the UK are presented as an example of the model outputs. These results show that a typical smoking cessation strategy costs approximately £1200 per life year saved and £22 000 per death averted.
CONCLUSIONS—The model successfully captures the complexity required to model smoking behaviour and associated mortality, morbidity, and health care costs. Furthermore, the interface provides the results in a simple and flexible way so as to be useful to a variety of audiences and to simulate a variety of smoking cessation methods.


Keywords: consequences of smoking; model; health consequences; economic consequences

Full Text

The Full Text of this article is available as a PDF (216.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barendregt J. J., Bonneux L., van der Maas P. J. The health care costs of smoking. N Engl J Med. 1997 Oct 9;337(15):1052–1057. doi: 10.1056/NEJM199710093371506. [DOI] [PubMed] [Google Scholar]
  2. Briggs A., Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998 Apr;13(4):397–409. doi: 10.2165/00019053-199813040-00003. [DOI] [PubMed] [Google Scholar]
  3. Eisenberg J. M. Clinical economics. A guide to the economic analysis of clinical practices. JAMA. 1989 Nov 24;262(20):2879–2886. doi: 10.1001/jama.262.20.2879. [DOI] [PubMed] [Google Scholar]
  4. Fries J. F. The health care costs of smoking. N Engl J Med. 1998 Feb 12;338(7):470–472. [PubMed] [Google Scholar]
  5. Halpern M. T., Luce B. R., Brown R. E., Geneste B. Health and economic outcomes modeling practices: a suggested framework. Value Health. 1998 Jul-Aug;1(2):131–147. doi: 10.1046/j.1524-4733.1998.120131.x. [DOI] [PubMed] [Google Scholar]
  6. Heaney D. The health care costs of smoking. N Engl J Med. 1998 Feb 12;338(7):471–472. [PubMed] [Google Scholar]
  7. Hodgson T. A. The health care costs of smoking. N Engl J Med. 1998 Feb 12;338(7):470–472. doi: 10.1056/NEJM199802123380713. [DOI] [PubMed] [Google Scholar]
  8. Jorenby D. E., Leischow S. J., Nides M. A., Rennard S. I., Johnston J. A., Hughes A. R., Smith S. S., Muramoto M. L., Daughton D. M., Doan K. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685–691. doi: 10.1056/NEJM199903043400903. [DOI] [PubMed] [Google Scholar]
  9. Law M., Tang J. L. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med. 1995 Oct 9;155(18):1933–1941. [PubMed] [Google Scholar]
  10. Leistikow B. N., Miller T. R. The health care costs of smoking. N Engl J Med. 1998 Feb 12;338(7):471–472. [PubMed] [Google Scholar]
  11. Makomaski Illing E. M., Kaiserman M. J. Mortality attributable to tobacco use in Canada and its regions, 1994 and 1996. Chronic Dis Can. 1999;20(3):111–117. [PubMed] [Google Scholar]
  12. Miller L. S., Zhang X., Novotny T., Rice D. P., Max W. State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993. Public Health Rep. 1998 Mar-Apr;113(2):140–151. [PMC free article] [PubMed] [Google Scholar]
  13. Miller L. S., Zhang X., Novotny T., Rice D. P. Smoking estimate correction. Public Health Rep. 1998 May-Jun;113(3):191–192. [PMC free article] [PubMed] [Google Scholar]
  14. Miller L. S., Zhang X., Rice D. P., Max W. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep. 1998 Sep-Oct;113(5):447–458. [PMC free article] [PubMed] [Google Scholar]
  15. Peto R., Chen Z. M., Boreham J. Tobacco--the growing epidemic. Nat Med. 1999 Jan;5(1):15–17. doi: 10.1038/4691. [DOI] [PubMed] [Google Scholar]
  16. Raw M., McNeill A., West R. Smoking cessation: evidence based recommendations for the healthcare system. BMJ. 1999 Jan 16;318(7177):182–185. doi: 10.1136/bmj.318.7177.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Res P., Blom B., Hori T., Weijer K., Spits H. Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development. J Exp Med. 1997 Jan 6;185(1):141–151. doi: 10.1084/jem.185.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sauter C. The health care costs of smoking. N Engl J Med. 1998 Feb 12;338(7):471–472. [PubMed] [Google Scholar]
  19. Shultz J. M., Novotny T. E., Rice D. P. Quantifying the disease impact of cigarette smoking with SAMMEC II software. Public Health Rep. 1991 May-Jun;106(3):326–333. [PMC free article] [PubMed] [Google Scholar]
  20. Sonnenberg F. A., Beck J. R. Markov models in medical decision making: a practical guide. Med Decis Making. 1993 Oct-Dec;13(4):322–338. doi: 10.1177/0272989X9301300409. [DOI] [PubMed] [Google Scholar]
  21. Tengs T. O., Adams M. E., Pliskin J. S., Safran D. G., Siegel J. E., Weinstein M. C., Graham J. D. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995 Jun;15(3):369–390. doi: 10.1111/j.1539-6924.1995.tb00330.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Additional Tables and Appendix 2]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES